Download 
|
< Back |
| 23 Oct 2025 | |
| Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40mg/20 mL (2 mg/mL), 150mg/30mL (5 mg/mL), and 200mg/20 mL (10 mg/mL) Single-Dose Vials | |
| View all announcements for Glenmark Pharmaceuticals Ltd | Source: BSE India |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback